scispace - formally typeset
Journal ArticleDOI

Platinum-195 NMR kinetic and mechanistic studies of cis- and trans-diamminedichloroplatinum(II) binding to DNA

TLDR
The kinetics and mechanism of binding of the anticancer drug cis-diamminedichloroplatinum(II), or cis-DDP, and its inactive trans isomer to chicken erythrocyte DNA at 37 o C have been investigated by 195 Pt NMR spectroscopy.
Abstract
The kinetics and mechanism of binding of the anticancer drug cis-diamminedichloroplatinum(II), or cis-DDP, and its inactive trans isomer to chicken erythrocyte DNA at 37 o C have been investigated by 195 Pt NMR spectroscopy. Both cis-and trans-DDP bind to DNA by two successive pseudo-first-order processes, forming monofunctional adducts ( 195 Pt NMR shifts near -2300 ppm) that subsequently close to bifunctional lesions (chemical shifts near -2450 ppm)

read more

Citations
More filters
Journal ArticleDOI

The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs

TL;DR: Recently, there has been a surge of activity, based on a great deal of mechanistic information, aimed at developing nonclassical platinum complexes that operate via mechanisms of action distinct from those of the approved drugs as mentioned in this paper.
Journal ArticleDOI

Oxaliplatin: A review of preclinical and clinical studies

TL;DR: Its single agent and combination therapy data in ovarian cancer confirm its non-cross resistance with cisplatin/carboplatin and topoisomerase I inhibitors, and the absence of hematologic dose-limiting toxicity have made oxaliplatin an attractive compound for combinations.
Journal ArticleDOI

Formation and repair of interstrand cross-links in DNA

TL;DR: Bifunctional alkylating agents, platinum compounds, and psoralen can produce covalent adducts with DNA bases on both strands of DNA, leading ultimately to the formation of interstrand cross-links, which can act as absolute blocks to DNA replication and/or DNA transcription.
Related Papers (5)